BLS vs NXN

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BLS

BLSPHARMA FPO [BLS]

56MEDIUM

NXN

NEXSEN LTD FPO [NXN]

51MEDIUM

Score Breakdown

BLS NXN
Technical
49
62
Catalyst
55
50
Sentiment
50
50
Fundamental
96
66
Momentum
84
54
Risk Gate
50
42

Key Metrics

BLS Metric NXN
$193.2MMarket Cap$59.1M
218KAvg Volume (20d)166K
+0.0%Short InterestN/A
$1.10052-Week High$0.345
$0.33052-Week Low$0.130
+1.8%Daily Change+3.5%
$0.855Reference Price$0.295
+66.1%ROEN/A
+18.7%Profit MarginN/A

Active Signals

BLS Signals

●MACD momentum is losing steam
●Drifting lower — down 8.1% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (4.0x)
●Strong revenue growth (+150%)
●Piotroski F-Score strong (8/9, low-confidence approx)

NXN Signals

●Trading above both moving averages — the trend is your friend here
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
●Adequate cash runway (8 quarters)
●Very high P/S ratio (63.4x)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)
●CANSLIM S: Tight float (32%)

Ask Scout AI to compare BLS and NXN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs OCC →BLS vs PAR →BLS vs PCK →BLS vs PIQ →BLS vs RHY →
BLS Full Analysis → NXN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).